We are live on ! Find out more
Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Portfolio holdings

AUM $34B
1-Year Est. Return 6.31%
This Fund
S&P 500
This Quarter Est. Return
-1.41%
1 Year Est. Return
+6.31%
3 Year Est. Return
+45.79%
5 Year Est. Return
+60.99%
10 Year Est. Return
+604.27%
AUM
$30.2B
AUM Growth
-$1.53B
Cap. Flow
-$402M
Cap. Flow %
-1.33%
Top 10 Hldgs %
18.07%
Holding
679
New
70
Increased
200
Reduced
228
Closed
25

Top Buys

Rank Stock Value
1
RVLV icon
Revolve Group
RVLV
+$174M
2
GSHD icon
Goosehead Insurance
GSHD
+$61.4M
3
HLLY icon
Holley
HLLY
+$56.4M
4
NCNO icon
nCino
NCNO
+$48.2M
5
MC icon
Moelis & Co
MC
+$33.2M

Sector Composition

Rank Sector Weight
1 Industrials 27.93%
2 Financials 21.76%
3 Technology 20.83%
4 Consumer Discretionary 10.09%
5 Healthcare 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
626
D.R. Horton
DHI
$40.8B
$1K ﹤0.01%
21
GE icon
627
GE Aerospace
GE
$379B
$1K ﹤0.01%
19
HERO icon
628
Global X Video Games & Esports ETF
HERO
$67.3M
$1K ﹤0.01%
50
HPQ icon
629
HP
HPQ
$26.8B
$1K ﹤0.01%
46
-35,624
-100% -$1.09M
LEA icon
630
Lear
LEA
$8.07B
$1K ﹤0.01%
8
LHX icon
631
L3Harris
LHX
$54.1B
$1K ﹤0.01%
+6
New +$1.38K
NUE icon
632
Nucor
NUE
$61.7B
$1K ﹤0.01%
+7
New +$878
PSIL icon
633
AdvisorShares Psychedelics ETF
PSIL
$52.9M
$1K ﹤0.01%
31
RF icon
634
Regions Financial
RF
$26.9B
$1K ﹤0.01%
+27
New +$570
VNT icon
635
Vontier
VNT
$4.52B
$1K ﹤0.01%
33
VTRS icon
636
Viatris
VTRS
$18.5B
$1K ﹤0.01%
73
ZBH icon
637
Zimmer Biomet
ZBH
$18.7B
$1K ﹤0.01%
12
MACK
638
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1K ﹤0.01%
300
SIVB
639
DELISTED
SVB Financial Group
SIVB
$1K ﹤0.01%
+2
New +$805
ADM icon
640
Archer Daniels Midland
ADM
$38.4B
$0 ﹤0.01%
+6
New +$494
AIG icon
641
American International
AIG
$39.8B
$0 ﹤0.01%
+9
New +$473
ALLY icon
642
Ally Financial
ALLY
$13.5B
$0 ﹤0.01%
+9
New +$299
ANIK icon
643
Anika Therapeutics
ANIK
$295M
$0 ﹤0.01%
12
-108,938
-100% -$2.51M
APD icon
644
Air Products & Chemicals
APD
$67.7B
$0 ﹤0.01%
2
AXTA icon
645
Axalta
AXTA
$7.98B
-483
Closed -$11K
BIIB icon
646
Biogen
BIIB
$30.9B
-7
Closed -$1K
BKR icon
647
Baker Hughes
BKR
$63.8B
$0 ﹤0.01%
+13
New +$325
CASS icon
648
Cass Information Systems
CASS
$742M
$0 ﹤0.01%
1
CHEF icon
649
Chefs' Warehouse
CHEF
$4.53B
-2,241,818
Closed -$87.2M
EEMS icon
650
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$379M
-2,303
Closed -$111K

Similar funds

Kayne Anderson Rudnick Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Kayne Anderson Rudnick Investment Management held 679 positions worth $30.2B, down 4.8% from $31.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Kayne Anderson Rudnick Investment Management's Q3 2022 filing shows 70 new, 200 increased, 228 reduced and 25 closed positions. Its largest new stake was DoubleVerify: 880,971 shares worth $24.1M. The largest sale was Elanco Animal Health, an estimated $179M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Kayne Anderson Rudnick Investment Management's largest Q3 2022 buy was DoubleVerify: 880,971 shares worth $24.1M.
  • Kayne Anderson Rudnick Investment Management added most to Revolve Group in Q3 2022, an estimated $174M increase.
  • Kayne Anderson Rudnick Investment Management's biggest Q3 2022 reduction was Elanco Animal Health, cutting an estimated $179M.
  • Kayne Anderson Rudnick Investment Management fully exited Chefs' Warehouse in Q3 2022, selling an estimated $87.2M.
  • Kayne Anderson Rudnick Investment Management's ten largest holdings make up 18% of its $30.2B portfolio in Q3 2022.
  • Kayne Anderson Rudnick Investment Management opened 70 new positions and closed 25 in Q3 2022.
  • Kayne Anderson Rudnick Investment Management's portfolio value fell 4.8% quarter-over-quarter to $30.2B.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.